LL-340001
LL-340001 is the receptor-active metabolite released after hydrolysis of Elunetirom (HY-160207) by FAAH in the central nervous system. LL-340001 acts as a thyroid hormone receptor (TR) agonist, with potent full agonist activity at both TRα and TRβ. LL-340001 exhibits neuronal plasticity activity and can activate programs related to neuroplasticity and mitochondrial biogenesis in neuronal systems. LL-340001 can be used in the research of major depressive disorder and bipolar depression.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2046137-49-7
- Formel: C18H18Cl2O4
- Molecular Weight:369.24
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
LL-340001 (1-30 nM, 3 μM; 72 h) increases the number of MAP-2-positive neurons, neurite length, number of branches, and number of neurite terminals in primary cortical neurons from immature rats within 72 hours, and exhibits potent activity in the low nanomolar range[1].
The increase in the number of MAP-2-positive neurons induced by LL-340001 (3-30 nM; 73 h) in immature primary rat cortical neurons is sensitive to TrkB inhibition but independent of the 5-HT2A signaling pathway, whereas its neuritogenic effect is not consistently sensitive to TrkB antagonism[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 2046137-49-7
-
Molecular Weight 369.24
-
Formel C18H18Cl2O4
-
SMILES
CC(C)C1=C(O)C=CC(CC2=C(Cl)C=C(OCC(O)=O)C=C2Cl)=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)